CERT

Certara, Inc. is a global leader in biosimulation software and technology-enabled services that support drug development and regulatory approval processes, headquartered in Princeton, New Jersey. The company provides model-informed drug development solutions that integrate proprietary software, scientific expertise, and clinical trial data to optimize drug candidate selection, clinical trial design, and regulatory submissions. Certara's platforms include population pharmacokinetic/pharmacodynamic modeling, quantitative systems pharmacology, clinical pharmacology, and regulatory science solutions used by pharmaceutical and biotechnology companies worldwide. The company serves over 2,000 biopharmaceutical companies and regulatory agencies. Certara's technologies help accelerate drug development timelines, reduce clinical trial costs, and improve the probability of regulatory success by using computational modeling and simulation to predict how drugs behave in humans before and during clinical testing.